These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 27788483)
1. Serum APN/CD13 as a novel diagnostic and prognostic biomarker of pancreatic cancer. Pang L; Zhang N; Xia Y; Wang D; Wang G; Meng X Oncotarget; 2016 Nov; 7(47):77854-77864. PubMed ID: 27788483 [TBL] [Abstract][Full Text] [Related]
2. Serum dickkopf-1 is a novel serological biomarker for the diagnosis and prognosis of pancreatic cancer. Han SX; Zhou X; Sui X; He CC; Cai MJ; Ma JL; Zhang YY; Zhou CY; Ma CX; Varela-Ramirez A; Zhu Q Oncotarget; 2015 Aug; 6(23):19907-17. PubMed ID: 26101916 [TBL] [Abstract][Full Text] [Related]
3. Low serum miR-373 predicts poor prognosis in patients with pancreatic cancer. Hua Y; Chen H; Wang L; Wang F; Wang P; Ning Z; Li Y; Liu L; Chen Z; Meng Z Cancer Biomark; 2017 Jul; 20(1):95-100. PubMed ID: 28759959 [TBL] [Abstract][Full Text] [Related]
4. Clinical significance of aminopeptidase N/CD13 expression in human pancreatic carcinoma. Ikeda N; Nakajima Y; Tokuhara T; Hattori N; Sho M; Kanehiro H; Miyake M Clin Cancer Res; 2003 Apr; 9(4):1503-8. PubMed ID: 12684426 [TBL] [Abstract][Full Text] [Related]
5. Expression and clinical significance of aminopeptidase N/CD13 in non-small cell lung cancer. Zhang Q; Wang J; Zhang H; Zhao D; Zhang Z; Zhang S J Cancer Res Ther; 2015; 11(1):223-8. PubMed ID: 25879366 [TBL] [Abstract][Full Text] [Related]
6. Serum miR-629 is a novel molecular marker for diagnosis and the prognosis of pancreatic cancer. Shi W; Lu Y; Gong R; Sun JJ; Liu G Eur Rev Med Pharmacol Sci; 2018 Aug; 22(16):5187-5193. PubMed ID: 30178840 [TBL] [Abstract][Full Text] [Related]
7. Trefoil factor(s) and CA19.9: A promising panel for early detection of pancreatic cancer. Jahan R; Ganguly K; Smith LM; Atri P; Carmicheal J; Sheinin Y; Rachagani S; Natarajan G; Brand RE; Macha MA; Grandgenett PM; Kaur S; Batra SK EBioMedicine; 2019 Apr; 42():375-385. PubMed ID: 30956167 [TBL] [Abstract][Full Text] [Related]
8. Relationship between S100A4 protein expression and pre-operative serum CA19.9 levels in pancreatic carcinoma and its prognostic significance. Jia F; Liu M; Li X; Zhang F; Yue S; Liu J World J Surg Oncol; 2019 Sep; 17(1):163. PubMed ID: 31526392 [TBL] [Abstract][Full Text] [Related]
9. Serum DJ-1 as a diagnostic marker and prognostic factor for pancreatic cancer. He XY; Liu BY; Yao WY; Zhao XJ; Zheng Z; Li JF; Yu BQ; Yuan YZ J Dig Dis; 2011 Apr; 12(2):131-7. PubMed ID: 21401899 [TBL] [Abstract][Full Text] [Related]
10. Validation of N-glycan markers that improve the performance of CA19-9 in pancreatic cancer. Zhao YP; Zhou PT; Ji WP; Wang H; Fang M; Wang MM; Yin YP; Jin G; Gao CF Clin Exp Med; 2017 Feb; 17(1):9-18. PubMed ID: 26714469 [TBL] [Abstract][Full Text] [Related]
11. Clinical significance of aminopeptidase N in non-small cell lung cancer. Tokuhara T; Hattori N; Ishida H; Hirai T; Higashiyama M; Kodama K; Miyake M Clin Cancer Res; 2006 Jul; 12(13):3971-8. PubMed ID: 16818694 [TBL] [Abstract][Full Text] [Related]
12. CD13/aminopeptidase N mRNA expression and enzyme activity in Systemic Lupus Erythematosus. Behzadi M; Ahmadzadeh A; Valizadeh M; Haji Molla Hoseini M; Yeganeh F Acta Reumatol Port; 2017; 42(2):162-167. PubMed ID: 28375196 [TBL] [Abstract][Full Text] [Related]
13. Pancreatic cancer serum biomarker PC-594: Diagnostic performance and comparison to CA19-9. Ritchie SA; Chitou B; Zheng Q; Jayasinghe D; Jin W; Mochizuki A; Goodenowe DB World J Gastroenterol; 2015 Jun; 21(21):6604-12. PubMed ID: 26074698 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of serum MUC5AC in combination with CA19-9 for the diagnosis of pancreatic cancer. Zhang J; Wang Y; Zhao T; Li Y; Tian L; Zhao J; Zhang J World J Surg Oncol; 2020 Feb; 18(1):31. PubMed ID: 32028958 [TBL] [Abstract][Full Text] [Related]
15. Plasma miR-22-3p, miR-642b-3p and miR-885-5p as diagnostic biomarkers for pancreatic cancer. Hussein NA; Kholy ZA; Anwar MM; Ahmad MA; Ahmad SM J Cancer Res Clin Oncol; 2017 Jan; 143(1):83-93. PubMed ID: 27631726 [TBL] [Abstract][Full Text] [Related]
16. Combined pretreatment serum CA19-9 and neutrophil-to-lymphocyte ratio as a potential prognostic factor in metastatic pancreatic cancer patients. Song JY; Chen MQ; Guo JH; Lian SF; Xu BH Medicine (Baltimore); 2018 Jan; 97(4):e9707. PubMed ID: 29369199 [TBL] [Abstract][Full Text] [Related]
17. Clinicopathological significance of aminopeptidase N/CD13 expression in human gastric carcinoma. Kawamura J; Shimada Y; Kitaichi H; Komoto I; Hashimoto Y; Kaganoi J; Miyake M; Yamasaki S; Kondo K; Imamura M Hepatogastroenterology; 2007; 54(73):36-40. PubMed ID: 17419227 [TBL] [Abstract][Full Text] [Related]
18. A Combination of MUC5AC and CA19-9 Improves the Diagnosis of Pancreatic Cancer: A Multicenter Study. Kaur S; Smith LM; Patel A; Menning M; Watley DC; Malik SS; Krishn SR; Mallya K; Aithal A; Sasson AR; Johansson SL; Jain M; Singh S; Guha S; Are C; Raimondo M; Hollingsworth MA; Brand RE; Batra SK Am J Gastroenterol; 2017 Jan; 112(1):172-183. PubMed ID: 27845339 [TBL] [Abstract][Full Text] [Related]
19. Aminopeptidase N is involved in cell motility and angiogenesis: its clinical significance in human colon cancer. Hashida H; Takabayashi A; Kanai M; Adachi M; Kondo K; Kohno N; Yamaoka Y; Miyake M Gastroenterology; 2002 Feb; 122(2):376-86. PubMed ID: 11832452 [TBL] [Abstract][Full Text] [Related]
20. Serum PCSK9 is a novel serological biomarker for the diagnosis and prognosis of pancreatic cancer. Xu Y; Xu Y; Yang Y; Zhang Z; Xiong Q; Zhu Q PeerJ; 2024; 12():e18018. PubMed ID: 39282119 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]